Thomas E Hoffman, MD
Dermatology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 20
- 4 carriers
- Office
- 1
Offices
1 location · Palo Alto Dermatology Institute · 6 clinicians in this group
Plans that list them
20 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hoffman’s office at (650) 546-4929 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
20 of 20 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G20623 · Current
Licensed to practise in California · since 1971 · expires 2028-10-31 · Tulane University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$2,192
Medicare paid this office $2,192 for 21 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Removal of nail tissue | 1-10 | None |
| Removal of skin lesions | 81 | More than 74% of doctors who do this |
| Removal of tissue | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 19 | More than 63% of doctors who do this |
Who their Medicare patients are
21 Original Medicare patients in 2024. Average age 75 · Health risk score 1.34. Sicker patients than 9 in 10 peers; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 67% · Coronary heart disease 52%.
The office billed $8,111, Medicare allowed $2,800 and paid $2,192; for 36 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 21 | 36 | 75 | 1.34 | $8,111 | $2,192 |
| 2023 | 465 | 3,719 | 77 | 0.93 | $291,837 | $144,054 |
| 2022 | 495 | 3,546 | 77 | 0.89 | $312,813 | $146,595 |
| 2021 | 455 | 3,898 | 77 | 0.90 | $315,532 | $144,919 |
| 2020 | 401 | 3,430 | 77 | 0.96 | $241,029 | $103,472 |
| 2019 | 505 | 4,992 | 77 | 0.93 | $346,463 | $154,737 |
| 2018 | 509 | 6,689 | 77 | 0.96 | $355,472 | $156,371 |
| 2017 | 516 | 4,038 | 76 | 0.95 | $358,414 | $160,490 |
| 2016 | 513 | 4,017 | 77 | 0.98 | $340,431 | $147,199 |
| 2015 | 549 | 4,254 | 76 | 0.89 | $342,737 | $151,455 |
| 2014 | 554 | 4,131 | 76 | 0.91 | $236,181 | $143,689 |
| 2013 | 613 | 4,165 | 76 | 0.95 | $251,520 | $158,794 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Short return visit (20+ min) | 286 | $31,577 | $74 |
| Destruction of precancer skin growth, 1 growth | 250 | $20,988 | $50 |
| Destruction of precancer skin growth, 2-14 growths | 212 | $12,453 | $6 |
| Destruction of skin growth, 1-14 growths | 89 | $10,325 | $99 |
| Destruction of precancer skin growth, 15 or more growths | 37 | $9,692 | $167 |
| Biopsy of related skin growth, first growth | 87 | $8,445 | $84 |
| Short return visit | 123 | $7,665 | $47 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 13 | $6,721 | None |
| Pathology examination of tissue using a microscope, intermediate complexity | 129 | $6,189 | $33 |
| Return visit (30+ min) | 41 | $4,773 | $95 |
| New patient visit (30+ min) | 56 | $4,228 | $76 |
| Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | 14 | $2,913 | $153 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 15 | $2,713 | $151 |
| Application of light to destroy precancer skin growth | 13 | $2,176 | $136 |
| New patient visit (15+ min) | 18 | $934 | $52 |
| Injection into skin growth, 1-7 growths | 12 | $449 | $37 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $10 | None |
2022: 16 services
| Short return visit (20+ min) | 260 | $27,003 | $72 |
| Destruction of precancer skin growth, 1 growth | 278 | $20,095 | $48 |
| Destruction of precancer skin growth, 2-14 growths | 224 | $11,280 | $7 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 24 | $11,112 | None |
| Destruction of skin growth, 1-14 growths | 115 | $11,011 | $87 |
| Destruction of precancer skin growth, 15 or more growths | 39 | $9,145 | $155 |
| Short return visit | 147 | $8,401 | $43 |
| Biopsy of related skin growth, first growth | 85 | $8,353 | $85 |
| Pathology examination of tissue using a microscope, intermediate complexity | 124 | $6,225 | $33 |
| Return visit (30+ min) | 47 | $5,773 | $105 |
| New patient visit (30+ min) | 56 | $4,396 | $78 |
| Application of light to destroy precancer skin growth | 24 | $3,664 | $136 |
| Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | 15 | $2,281 | $143 |
| New patient visit (45+ min) | 13 | $1,842 | $142 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 11 | $1,672 | $129 |
| New patient visit (15+ min) | 19 | $844 | $44 |
2021: 17 services
| Short return visit (20+ min) | 246 | $25,432 | $72 |
| Destruction of precancer skin growth, 1 growth | 241 | $18,476 | $49 |
| Destruction of skin growth, 1-14 growths | 103 | $11,809 | $101 |
| Biopsy of related skin growth, first growth | 102 | $9,950 | $85 |
| Destruction of precancer skin growth, 2-14 growths | 189 | $9,902 | $6 |
| Destruction of precancer skin growth, 15 or more growths | 35 | $8,999 | $158 |
| Short return visit | 130 | $8,960 | $48 |
| Pathology examination of tissue using a microscope, intermediate complexity | 138 | $7,031 | $34 |
| Return visit (30+ min) | 40 | $6,056 | $114 |
| New patient visit (30+ min) | 66 | $5,468 | $83 |
| Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | 16 | $2,663 | $166 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 15 | $2,644 | $176 |
| Application of light to destroy precancer skin growth | 12 | $2,121 | $152 |
| New patient visit (45+ min) | 14 | $1,684 | $120 |
| New patient visit (15+ min) | 15 | $799 | $53 |
| Injection into skin growth, 1-7 growths | 11 | $535 | $41 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $13 | None |
2020: 16 services
| Short return visit (20+ min) | 219 | $20,985 | $58 |
| Destruction of precancer skin growth, 1 growth | 209 | $13,892 | $44 |
| Destruction of skin growth, 1-14 growths | 80 | $8,992 | $95 |
| Destruction of precancer skin growth, 15 or more growths | 32 | $6,569 | $140 |
| Destruction of precancer skin growth, 2-14 growths | 165 | $6,047 | $5 |
| Short return visit | 141 | $6,000 | $34 |
| Biopsy of related skin growth, first growth | 63 | $5,394 | $77 |
| Pathology examination of tissue using a microscope, intermediate complexity | 100 | $4,971 | $35 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 14 | $2,857 | $150 |
| Return visit (30+ min) | 30 | $2,595 | $79 |
| New patient visit (30+ min) | 31 | $2,545 | $82 |
| Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | 11 | $1,726 | $144 |
| New patient visit (15+ min) | 26 | $1,377 | $53 |
| Application of light to destroy precancer skin growth | 12 | $1,265 | $90 |
| Injection into skin growth, 1-7 growths | 14 | $619 | $31 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $19 | None |
2019: 17 services
| Short return visit (20+ min) | 313 | $26,703 | $58 |
| Destruction of precancer skin growth, 1 growth | 297 | $20,222 | $45 |
| Destruction of skin growth, 1-14 growths | 133 | $14,314 | $92 |
| Destruction of precancer skin growth, 15 or more growths | 66 | $13,887 | $125 |
| Destruction of precancer skin growth, 2-14 growths | 247 | $10,588 | $5 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 19 | $10,271 | None |
| Short return visit | 172 | $8,400 | $35 |
| Biopsy of related skin growth, first growth | 92 | $8,253 | $81 |
| Pathology examination of tissue using a microscope, intermediate complexity | 129 | $7,684 | $35 |
| New patient visit (30+ min) | 53 | $4,319 | $81 |
| Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | 22 | $3,933 | $151 |
| Application of light to destroy precancer skin growth | 20 | $3,013 | $126 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 11 | $2,422 | $142 |
| Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | 12 | $1,696 | $121 |
| New patient visit (15+ min) | 25 | $1,466 | $59 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 11 | $1,445 | $120 |
| Biopsy of related skin growth, each additional growth | 11 | $690 | $49 |
2018: 18 services
| Short return visit (20+ min) | 303 | $27,086 | $60 |
| Destruction of precancer skin growth, 1 growth | 279 | $20,395 | $49 |
| Destruction of precancer skin growth, 15 or more growths | 80 | $16,169 | $129 |
| Destruction of skin growth, 1-14 growths | 97 | $12,216 | $102 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 24 | $11,761 | None |
| Destruction of precancer skin growth, 2-14 growths | 229 | $10,135 | $5 |
| Biopsy of single growth of skin and/or tissue | 94 | $8,950 | $87 |
| Short return visit | 172 | $8,104 | $36 |
| Pathology examination of tissue using a microscope, intermediate complexity | 134 | $7,084 | $37 |
| New patient visit (30+ min) | 57 | $4,525 | $79 |
| Application of light to destroy precancer skin growth | 29 | $3,770 | $111 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 20 | $3,077 | $154 |
| Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | 16 | $2,888 | $152 |
| New patient visit (15+ min) | 32 | $1,714 | $54 |
| Simple or single drainage of skin abscess | 14 | $1,569 | $105 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 11 | $1,269 | $115 |
| Injection into skin growth, 1-7 growths | 13 | $339 | $26 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $20 | None |
2017: 19 services
| Short return visit (20+ min) | 326 | $29,412 | $60 |
| Destruction of precancer skin growth, 1 growth | 263 | $18,962 | $48 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 29 | $13,597 | None |
| Destruction of precancer skin growth, 15 or more growths | 65 | $13,099 | $141 |
| Destruction of skin growth, 1-14 growths | 107 | $12,285 | $98 |
| Destruction of precancer skin growth, 2-14 growths | 220 | $9,748 | $5 |
| Biopsy of single growth of skin and/or tissue | 95 | $9,487 | $90 |
| Pathology examination of tissue using a microscope, intermediate complexity | 136 | $7,349 | $36 |
| Short return visit | 131 | $6,252 | $37 |
| New patient visit (30+ min) | 70 | $5,943 | $85 |
| Application of light to destroy precancer skin growth | 34 | $5,782 | $134 |
| Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | 21 | $3,321 | $158 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 17 | $2,801 | $165 |
| Return visit (30+ min) | 29 | $2,794 | $90 |
| New patient visit (15+ min) | 27 | $1,843 | $68 |
| Simple or single drainage of skin abscess | 12 | $1,259 | $105 |
| Biopsy of ear | 12 | $983 | $76 |
| Injection into skin growth, 1-7 growths | 12 | $325 | $27 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $15 | None |
2016: 14 services
| Short return visit (20+ min) | 343 | $30,989 | $58 |
| Destruction of precancer skin growth, 1 growth | 289 | $22,244 | $50 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 28 | $12,545 | None |
| Destruction of precancer skin growth, 2-14 growths | 225 | $10,997 | $5 |
| Destruction of precancer skin growth, 15 or more growths | 54 | $10,836 | $135 |
| Destruction of skin growth, 1-14 growths | 90 | $10,490 | $97 |
| Biopsy of single growth of skin and/or tissue | 95 | $9,828 | $90 |
| Pathology examination of tissue using a microscope, intermediate complexity | 131 | $6,536 | $36 |
| Short return visit | 151 | $6,483 | $35 |
| Application of light to destroy precancer skin growth | 28 | $4,153 | $122 |
| New patient visit (30+ min) | 46 | $3,694 | $80 |
| Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | 14 | $1,838 | $131 |
| Return visit (30+ min) | 25 | $1,674 | $64 |
| New patient visit (15+ min) | 24 | $1,359 | $57 |
2015: 16 services
| Destruction of precancer skin growth, 1 growth | 318 | $28,116 | $52 |
| Short return visit (20+ min) | 261 | $27,666 | $61 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 34 | $16,303 | None |
| Destruction of precancer skin growth, 2-14 growths | 262 | $11,750 | $5 |
| Biopsy of single growth of skin and/or tissue | 113 | $11,691 | $84 |
| Destruction of skin growth, 1-14 growths | 100 | $11,289 | $100 |
| Short return visit | 151 | $7,664 | $38 |
| Application of light to destroy precancer skin growth | 34 | $6,896 | $135 |
| Pathology examination of tissue using a microscope, intermediate complexity | 134 | $6,864 | $34 |
| New patient visit (15+ min) | 45 | $2,608 | $58 |
| New patient visit (30+ min) | 29 | $2,428 | $84 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 12 | $2,200 | $157 |
| Destruction of precancer skin growth, 15 or more growths | 12 | $2,045 | $146 |
| Injection into skin growth, 1-7 growths | 13 | $964 | $48 |
| Biopsy of each additional growth of skin and/or tissue | 15 | $487 | $29 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $31 | None |
2014: 12 services
| Destruction of precancer skin growth, 1 growth | 330 | $34,506 | $59 |
| Short return visit (20+ min) | 247 | $24,465 | $60 |
| Biopsy of single growth of skin and/or tissue | 146 | $16,102 | $87 |
| Destruction of precancer skin growth, 2-14 growths | 270 | $13,922 | $7 |
| Pathology examination of tissue using a microscope, intermediate complexity | 162 | $9,218 | $35 |
| Destruction of skin growth, 1-14 growths | 65 | $8,372 | $91 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 26 | $6,973 | None |
| Short return visit | 146 | $6,715 | $38 |
| Application of light to destroy precancer skin growth | 26 | $3,928 | $123 |
| New patient visit (30+ min) | 29 | $2,508 | $86 |
| New patient visit (15+ min) | 34 | $1,903 | $56 |
| Biopsy of each additional growth of skin and/or tissue | 27 | $939 | $28 |
2013: 16 services
| Destruction of precancer skin growth, 1 growth | 314 | $37,665 | $64 |
| Short return visit (20+ min) | 265 | $28,575 | $61 |
| Biopsy of single growth of skin and/or tissue | 138 | $15,018 | $89 |
| Destruction of precancer skin growth, 2-14 growths | 254 | $12,407 | $6 |
| Pathology examination of tissue using a microscope, intermediate complexity | 173 | $8,916 | $33 |
| Destruction of skin growth, 1-14 growths | 76 | $8,431 | $98 |
| Short return visit | 156 | $7,149 | $37 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 29 | $6,353 | None |
| Application of light to destroy precancer skin growth | 28 | $5,190 | $140 |
| New patient visit (30+ min) | 31 | $2,667 | $86 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 11 | $1,840 | $167 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | 11 | $1,659 | $151 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 11 | $1,611 | $134 |
| New patient visit (15+ min) | 36 | $1,575 | $44 |
| Simple or single drainage of skin abscess | 11 | $1,415 | $109 |
| Biopsy of each additional growth of skin and/or tissue | 16 | $550 | $31 |
Drugs they prescribed that Part D paid
$23,305
Pharmacies billed $23,305 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 103) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
93 generic and fewer than 11 brand-name prescriptions · $23,305 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Metronidazole | 17 | $1,228 | $72 |
Year by year
| 2024 | 103 | 40 | 0% (0) | None | $23,305 |
| 2023 | 500 | 182 | 0% (0) | None | $77,537 |
| 2022 | 554 | 207 | 0% (0) | 5% | $37,829 |
| 2021 | 616 | 220 | 0% (0) | 9% | $87,092 |
| 2020 | 618 | 197 | 0% (0) | 11% | $112,402 |
| 2019 | 463 | 192 | 0% (0) | 13% | $62,478 |
| 2018 | 442 | 199 | 0% (0) | 12% | $39,346 |
| 2017 | 462 | 202 | 0% (0) | 10% | $33,158 |
| 2016 | 382 | 156 | 0% (0) | 16% | $50,700 |
| 2015 | 487 | 179 | 0% (0) | 18% | $77,304 |
| 2014 | 527 | 217 | None | None | $60,044 |
| 2013 | 516 | 221 | None | None | $61,903 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Metronidazole | 50 | $3,425 | $69 |
| Clobetasol Propionate | 48 | $2,321 | $48 |
| Triamcinolone Acetonide | 73 | $1,649 | $23 |
| Fluorouracil | 17 | $1,626 | $96 |
| Fluocinolone Acetonide | 13 | $1,082 | $83 |
| Fluocinonide-E | 14 | $1,008 | $72 |
| Desonide | 22 | $873 | $40 |
| Fluocinonide | 16 | $861 | $54 |
| Alclometasone Dipropionate | 12 | $571 | $48 |
| Hydroxyzine | 28 | $344 | $12 |
| Clindamycin Phosphate | 15 | $337 | $22 |
| Clotrimazole-Betamethasone | 13 | $280 | $22 |
| Doxycycline Monohydrate | 11 | $200 | $18 |
| Minoxidil | 12 | $170 | $14 |
| Mupirocin | 15 | $120 | $8 |
| Gabapentin | 15 | $38 | $3 |
2022: 17 drugs
| Jublia | 12 | $10,908 | $909 |
| Metronidazole | 60 | $3,335 | $56 |
| Clobetasol Propionate | 34 | $2,298 | $68 |
| Fluocinonide | 25 | $1,413 | $57 |
| Fluorouracil | 14 | $1,207 | $86 |
| Triamcinolone Acetonide | 89 | $1,180 | $13 |
| Fluocinolone Acetonide | 17 | $1,169 | $69 |
| Clindamycin Phosphate | 24 | $825 | $34 |
| Alclometasone Dipropionate | 17 | $787 | $46 |
| Clotrimazole-Betamethasone | 16 | $495 | $31 |
| Amoxicillin-Clavulanate Potass | 18 | $223 | $12 |
| Ketoconazole | 13 | $206 | $16 |
| Minocycline | 11 | $172 | $16 |
| Mupirocin | 18 | $166 | $9 |
| Hydroxyzine | 24 | $119 | $5 |
| Doxazosin Mesylate | 12 | $54 | $5 |
| Losartan | 13 | $22 | $2 |
2021: 19 drugs
| Dupixent | 12 | $38,089 | $3,174 |
| Jublia | 12 | $10,806 | $901 |
| Metronidazole | 64 | $4,712 | $74 |
| Clobetasol Propionate | 54 | $3,354 | $62 |
| Fluocinonide | 23 | $1,919 | $83 |
| Fluorouracil | 15 | $1,603 | $107 |
| Fluocinolone Acetonide | 24 | $1,575 | $66 |
| Triamcinolone Acetonide | 90 | $1,382 | $15 |
| Fluocinonide-E | 12 | $1,347 | $112 |
| Nystatin-Triamcinolone | 19 | $1,068 | $56 |
| Desonide | 12 | $752 | $63 |
| Alclometasone Dipropionate | 18 | $743 | $41 |
| Ketoconazole | 19 | $297 | $16 |
| Desmopressin Acetate | 13 | $290 | $22 |
| Minocycline | 15 | $199 | $13 |
| Famciclovir | 12 | $186 | $15 |
| Mupirocin | 20 | $149 | $7 |
| Losartan | 14 | $102 | $7 |
| Doxazosin Mesylate | 12 | $82 | $7 |
2020: 21 drugs
| Dupixent | 21 | $65,066 | $3,098 |
| Acitretin | 11 | $7,671 | $697 |
| Metronidazole | 33 | $3,641 | $110 |
| Clobetasol Propionate | 55 | $3,089 | $56 |
| Fluocinonide-E | 26 | $2,734 | $105 |
| Fluorouracil | 20 | $2,562 | $128 |
| Triamcinolone Acetonide | 95 | $1,561 | $16 |
| Fluocinolone Acetonide | 19 | $1,388 | $73 |
| Alclometasone Dipropionate | 20 | $927 | $46 |
| Fluocinonide | 17 | $856 | $50 |
| Clindamycin Phosphate | 11 | $409 | $37 |
| Clotrimazole-Betamethasone | 17 | $331 | $19 |
| Valacyclovir | 12 | $275 | $23 |
| Mupirocin | 27 | $234 | $9 |
| Hydroxyzine | 15 | $174 | $12 |
| Ketoconazole | 11 | $152 | $14 |
| Famciclovir | 12 | $144 | $12 |
| Desmopressin Acetate | 11 | $138 | $13 |
| Atorvastatin | 11 | $47 | $4 |
| Cephalexin | 14 | $38 | $3 |
| Losartan | 14 | $37 | $3 |
2019: 14 drugs
| Acitretin | 12 | $6,235 | $520 |
| Clobetasol Propionate | 47 | $2,798 | $60 |
| Metronidazole | 18 | $2,519 | $140 |
| Fluorouracil | 18 | $2,067 | $115 |
| Fluocinonide | 32 | $1,921 | $60 |
| Fluocinolone Acetonide | 12 | $1,165 | $97 |
| Alclometasone Dipropionate | 26 | $944 | $36 |
| Desonide | 13 | $903 | $69 |
| Triamcinolone Acetonide | 52 | $711 | $14 |
| Famciclovir | 15 | $208 | $14 |
| Mupirocin | 20 | $204 | $10 |
| Ketoconazole | 11 | $172 | $16 |
| Hydroxyzine | 19 | $75 | $4 |
| Atorvastatin | 12 | $64 | $5 |
2018: 16 drugs
| Clobetasol Propionate | 75 | $5,499 | $73 |
| Metronidazole | 35 | $4,070 | $116 |
| Fluocinolone Acetonide | 22 | $2,276 | $103 |
| Fluocinonide | 22 | $1,450 | $66 |
| Nystatin-Triamcinolone | 11 | $561 | $51 |
| Alclometasone Dipropionate | 18 | $554 | $31 |
| Triamcinolone Acetonide | 33 | $483 | $15 |
| Clindamycin Phosphate | 11 | $479 | $44 |
| Desonide | 14 | $454 | $32 |
| Doxazosin Mesylate | 13 | $220 | $17 |
| Mupirocin | 17 | $203 | $12 |
| Famciclovir | 11 | $184 | $17 |
| Hydroxyzine | 11 | $133 | $12 |
| Ketoconazole | 11 | $132 | $12 |
| Azithromycin | 11 | $73 | $7 |
| Atorvastatin | 12 | $70 | $6 |
2017: 12 drugs
| Clobetasol Propionate | 81 | $8,243 | $102 |
| Metronidazole | 26 | $2,956 | $114 |
| Fluocinolone Acetonide | 19 | $2,263 | $119 |
| Fluocinonide | 22 | $1,001 | $46 |
| Alclometasone Dipropionate | 17 | $849 | $50 |
| Desonide | 16 | $656 | $41 |
| Triamcinolone Acetonide | 46 | $485 | $11 |
| Clindamycin Phosphate | 12 | $406 | $34 |
| Famciclovir | 19 | $397 | $21 |
| Minocycline | 13 | $240 | $18 |
| Ketoconazole | 18 | $203 | $11 |
| Azithromycin | 14 | $87 | $6 |
2016: 12 drugs
| Clobetasol Propionate | 66 | $11,143 | $169 |
| Metronidazole | 28 | $4,115 | $147 |
| Fluocinolone Acetonide | 19 | $2,217 | $117 |
| Fluocinonide | 23 | $1,701 | $74 |
| Fluocinonide-E | 12 | $1,543 | $129 |
| Desonide | 14 | $754 | $54 |
| Alclometasone Dipropionate | 11 | $350 | $32 |
| Triamcinolone Acetonide | 38 | $300 | $8 |
| Doxycycline Monohydrate | 20 | $286 | $14 |
| Famciclovir | 16 | $255 | $16 |
| Minocycline | 11 | $251 | $23 |
| Ketoconazole | 14 | $228 | $16 |
2015: 16 drugs
| Clobetasol Propionate | 73 | $13,504 | $185 |
| Acitretin | 12 | $7,455 | $621 |
| Oracea | 11 | $5,823 | $529 |
| Metronidazole | 33 | $5,228 | $158 |
| Desonide | 35 | $4,261 | $122 |
| Fluorouracil | 11 | $2,007 | $182 |
| Triamcinolone Acetonide | 46 | $1,917 | $42 |
| Fluocinonide | 23 | $1,582 | $69 |
| Fluocinolone Acetonide | 11 | $1,488 | $135 |
| Doxycycline Hyclate | 18 | $1,229 | $68 |
| Nystatin-Triamcinolone | 11 | $1,149 | $104 |
| Minocycline | 25 | $534 | $21 |
| Ketoconazole | 19 | $264 | $14 |
| Mupirocin | 16 | $207 | $13 |
| Famciclovir | 13 | $191 | $15 |
| Azithromycin | 14 | $134 | $10 |
2014: 15 drugs
| Metronidazole | 38 | $6,397 | $168 |
| Clobetasol Propionate | 62 | $3,502 | $56 |
| Fluocinolone Acetonide | 14 | $2,078 | $148 |
| Doxycycline Hyclate | 12 | $1,958 | $163 |
| Desonide | 17 | $1,913 | $113 |
| Nystatin-Triamcinolone | 16 | $1,833 | $115 |
| Fluocinonide | 48 | $1,706 | $36 |
| Fluocinonide-E | 16 | $1,029 | $64 |
| Triamcinolone Acetonide | 34 | $866 | $25 |
| Famciclovir | 12 | $389 | $32 |
| Mupirocin | 25 | $314 | $13 |
| Ketoconazole | 24 | $305 | $13 |
| Minocycline | 18 | $230 | $13 |
| Hydroxyzine | 18 | $129 | $7 |
| Cephalexin | 14 | $59 | $4 |
2013: 12 drugs
| Clobetasol Propionate | 91 | $3,486 | $38 |
| Desonide | 27 | $2,453 | $91 |
| Metronidazole | 20 | $1,788 | $89 |
| Fluocinonide | 47 | $1,624 | $35 |
| Triamcinolone Acetonide | 36 | $731 | $20 |
| Ketoconazole | 33 | $528 | $16 |
| Fluocinonide-E | 13 | $521 | $40 |
| Dapsone | 12 | $307 | $26 |
| Mupirocin | 21 | $300 | $14 |
| Minocycline | 12 | $221 | $18 |
| Azithromycin | 18 | $190 | $11 |
| Cephalexin | 11 | $49 | $4 |
Money from drug and device companies
$4,198 in 2025
| 2025 | 13 | 44 | $3,071 | $4,198 |
| 2024 | 2 | 12 | $3,710 | $3,739 |
| 2023 | 13 | 30 | $3,288 | $4,019 |
| 2022 | 15 | 41 | None | $1,905 |
| 2021 | 17 | 54 | None | $1,437 |
| 2020 | 17 | 49 | None | $981 |
| 2019 | 21 | 76 | None | $2,197 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Rinvoq | $3,352 | 17 payments
|
| Regeneron Healthcare Solutions | Dupixent | $284 | 11 payments
|
| Genzyme | Dupixent | $182 | 2 payments
|
| Amgen | Otezla | $64 | 2 payments
|
| LEO Pharma | Adbry | $52 | 2 payments
|
| Arcutis Biotherapeutics | Zoryve | $52 | 2 payments
|
See all 44 published payments
| Abbvie | Paid to speak or teach · 2025-12-18 | None | $416 |
| Regeneron Healthcare Solutions | Meals · 2025-12-16 | Libtayo | $37 |
| LEO Pharma | Meals · 2025-11-13 | Anzupgo | $24 |
| Abbvie | Meals · 2025-10-21 | Rinvoq | $128 |
| Abbvie | Meals · 2025-10-16 | Rinvoq | $31 |
| Pfizer | Meals · 2025-10-13 | Xeljanz | $22 |
| Regeneron Healthcare Solutions | Meals · 2025-10-09 | Dupixent | $22 |
| Abbvie | Paid to speak or teach · 2025-10-08 | None | $197 |
| Regeneron Healthcare Solutions | Meals · 2025-10-01 | None | $122 |
| LEO Pharma | Meals · 2025-09-26 | Adbry | $28 |
| Abbvie | Meals · 2025-09-23 | Rinvoq | $27 |
| Abbvie | Paid to speak or teach · 2025-09-16 | None | $103 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-09-16 | Cabtreo | $25 |
| Abbvie | Meals · 2025-08-21 | Skyrizi | $26 |
| Verrica Pharmaceuticals | Meals · 2025-08-14 | Ycanth | $23 |
| Abbvie | Paid to speak or teach · 2025-08-07 | None | $177 |
| Regeneron Healthcare Solutions | Meals · 2025-07-16 | Dupixent | $10 |
| Verrica Pharmaceuticals | Meals · 2025-07-15 | Ycanth | $15 |
| Arcutis Biotherapeutics | Meals · 2025-07-03 | Zoryve | $24 |
| Abbvie | Paid to speak or teach · 2025-07-02 | None | $157 |
| Regeneron Healthcare Solutions | Meals · 2025-07-01 | Dupixent | $14 |
| Abbvie | Meals · 2025-06-30 | Rinvoq | $21 |
| Amgen | Meals · 2025-06-27 | Otezla | $32 |
| Incyte | Meals · 2025-06-17 | Opzelura | $29 |
| Amgen | Meals · 2025-06-13 | Otezla | $32 |
| Galderma Laboratories L.P. | Meals · 2025-06-10 | Nemluvio | $31 |
| Abbvie | Paid to speak or teach · 2025-06-03 | None | $419 |
| Lilly USA | Meals · 2025-05-22 | Ebglyss | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-05-20 | Dupixent | $15 |
| Abbvie | Meals · 2025-05-13 | Rinvoq | $26 |
| Abbvie | Paid to speak or teach · 2025-05-02 | None | $741 |
| Almirall | Meals · 2025-04-30 | Klisyri | $39 |
| Genzyme | Meals · 2025-04-28 | Dupixent | $35 |
| Regeneron Healthcare Solutions | Meals · 2025-04-23 | Dupixent | $8 |
| Regeneron Healthcare Solutions | Meals · 2025-04-23 | Dupixent | $2 |
| Abbvie | Meals · 2025-04-22 | Rinvoq | $23 |
| Abbvie | Paid to speak or teach · 2025-04-07 | None | $429 |
| Arcutis Biotherapeutics | Meals · 2025-04-03 | Zoryve | $28 |
| Genzyme | Meals · 2025-03-27 | Dupixent | $146 |
| Regeneron Healthcare Solutions | Meals · 2025-03-25 | Dupixent | $12 |
| Regeneron Healthcare Solutions | Meals · 2025-03-22 | Dupixent | $30 |
| Regeneron Healthcare Solutions | Meals · 2025-03-11 | Dupixent | $11 |
| Abbvie | Paid to speak or teach · 2025-02-04 | None | $273 |
| Abbvie | Paid to speak or teach · 2025-01-07 | None | $161 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,739
| Abbvie | None | $3,710 | 11 payments
|
| Organogenesis | None | $29 | 1 payment
|
2023: $4,019
| Abbvie | Skyrizi | $3,334 | 12 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $366 | 4 payments
|
| Genzyme | Dupixent | $56 | 2 payments
|
| Sun Pharmaceutical Industries | Winlevi | $42 | 2 payments
|
| Pfizer | Cibinqo | $41 | 2 payments
|
| Amgen | Otezla | $32 | 1 payment
|
| Incyte | Opzelura | $28 | 1 payment
|
| LEO Pharma | Adbry | $25 | 1 payment
|
| Almirall | Klisyri | $23 | 1 payment
|
| Arcutis Biotherapeutics | None | $22 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Arazlo | $21 | 1 payment
|
| Janssen Biotech | Tremfya | $14 | 1 payment
|
| Dermavant Sciences | Vtama | $13 | 1 payment
|
2022: $1,905
| E.R. Squibb & Sons L.L.C. | Sotyktu | $631 | 6 payments
|
| Regeneron Healthcare Solutions | Dupixent | $287 | 5 payments
|
| Sun Pharmaceutical Industries | Ilumya | $248 | 9 payments
|
| Allergan | Botox | $224 | 3 payments
|
| Ucb | None | $88 | 1 payment
|
| Abbvie | Rinvoq | $72 | 3 payments
|
| Pfizer | Cibinqo | $72 | 1 payment
|
| Janssen Biotech | Remicade | $61 | 3 payments
|
| Incyte | Opzelura | $43 | 2 payments
|
| LEO Pharma | Adbry | $43 | 2 payments
|
| Galderma Laboratories L.P. | Aklief | $40 | 2 payments
|
| Genzyme | Dupixent | $31 | 1 payment
|
| Amgen | Otezla | $25 | 1 payment
|
| Journey Medical | Qbrexza | $21 | 1 payment
|
| Almirall | Klisyri | $20 | 1 payment
|
2021: $1,437
| Regeneron Healthcare Solutions | Dupixent | $253 | 5 payments
|
| Janssen Biotech | Tremfya | $199 | 8 payments
|
| Galderma Laboratories L.P. | Aklief | $186 | 10 payments
|
| Sanofi-Aventis U.S. | Dupixent | $122 | 3 payments
|
| LEO Pharma | Enstilar | $114 | 5 payments
|
| E.R. Squibb & Sons L.L.C. | None | $94 | 1 payment
|
| Almirall | Seysara | $76 | 4 payments
|
| Ortho Dermatologics a division of Bausch Health US | Duobrii | $67 | 3 payments
|
| AbbVie | Skyrizi | $65 | 3 payments
|
| Allergan | Botox | $65 | 3 payments
|
| Sun Pharmaceutical Industries | Ilumya | $53 | 2 payments
|
| Lilly USA | Taltz | $44 | 2 payments
|
| Genzyme | Dupixent | $23 | 1 payment
|
| Incyte | Opzelura | $22 | 1 payment
|
| Dermira | Qbrexza | $20 | 1 payment
|
| EPI Health | Cloderm | $18 | 1 payment
|
| Pfizer | Eucrisa | $15 | 1 payment
|
2020: $981
| Janssen Biotech | Tremfya | $267 | 9 payments
|
| LEO Pharma | Enstilar | $119 | 10 payments
|
| Galderma Laboratories L.P. | Oracea | $110 | 6 payments
|
| Pfizer | Eucrisa | $99 | 4 payments
|
| Allergan | Botox Cosmetic | $50 | 2 payments
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $50 | 3 payments
|
| Almirall | Seysara | $42 | 2 payments
|
| Sun Pharmaceutical Industries | Ilumya | $41 | 2 payments
|
| Lilly USA | Taltz | $41 | 2 payments
|
| Dermira | Qbrexza | $23 | 1 payment
|
| Biofrontera | Ameluz | $22 | 2 payments
|
| EPI Health | Sitavig | $22 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $22 | 1 payment
|
| Amgen | Otezla | $19 | 1 payment
|
| AbbVie | Skyrizi | $18 | 1 payment
|
| Sanofi-Aventis U.S. | Dupixent | $18 | 1 payment
|
| Merz North America | None | $17 | 1 payment
|
2019: $2,197
| Sun Pharmaceutical Industries | Ilumya | $375 | 6 payments
|
| Ortho Dermatologics a division of Bausch Health US | Altreno | $337 | 11 payments
|
| Allergan | Botox Cosmetic | $287 | 6 payments
|
| Pfizer | Eucrisa | $218 | 7 payments
|
| Celgene | Otezla | $148 | 5 payments
|
| Lilly USA | Taltz | $121 | 6 payments
|
| Stemline Therapeutics | Elzonris | $86 | 1 payment
|
| AbbVie | Humira | $72 | 4 payments
|
| Mayne Pharma | Doryx | $69 | 3 payments
|
| LEO Pharma | Picato | $65 | 3 payments
|
| Janssen Biotech | Tremfya | $63 | 4 payments
|
| Galderma Laboratories L.P. | Epiduo Forte | $54 | 3 payments
|
| Merz North America | Xeomin | $48 | 3 payments
|
| Biofrontera | Ameluz | $45 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $45 | 2 payments
|
| EPI Health | Sitavig | $43 | 2 payments
|
| Dermira | None | $38 | 2 payments
|
| Almirall | Seysara | $24 | 1 payment
|
| Genzyme | Dupixent | $22 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $20 | 1 payment
|
| Janssen Scientific Affairs | Tremfya | $18 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1063435741
- Licence
- CA G20623California G20623: Current · expires 2028-10-31
- Trained
- Tulane University School of Medicine, 1970
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X); Federal specialty code 207ZD0900X (207ZD0900X)
- Mailing address
- 301 High St, Palo Alto, CA, 94301
- NPI first listed
- 2006-07-25
- NPI last updated
- 2025-06-19
- NPI record certified
- 2025-06-18
This is when the NPI record was last certified, not a medical board exam.